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Metastasis to the ovaries from transitional cell carcinoma of 
the bladder and renal pelvis: a report of two cases
Maria Lee, Yong Wook Jung, Sang Wun Kim, Sung Hoon Kim, Young Tae Kim
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
Ovarian metastases from a primary urinary tract carcinoma are extremely rare. This can be difficult to distinguish 
from transitional cell carcinomas (TCC) of ovarian origin because of histologic similarity. A 65-year-old woman who 
was diagnosed with renal pelvis TCC 4 months prior was referred for evaluation of a left ovarian mass. A 47-year-old 
woman who underwent radical cystectomy due to bladder TCC 1 year ago was referred because of a right ovarian 
mass. Both patients underwent a bilateral salpingo-oophorectomy. The tumor cells had morphology identical to those 
of the primary urinary tract tumors. Gynecologic oncologists should consider metastatic TCC of the ovary from 
urinary tract origin, as well as breast, and gastrointestinal tract origins.
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INTRODUCTION
Ovarian metastases from a primary urinary tract carcinoma, 
especially those mimicking primary ovarian carcinoma, are 
very rare. The tumors that metastasize to the ovary commonly 
arise in the colorectum, breast, endometrium, stomach, cer-
vix, pancreas, appendix.1 In one autopsy study, ovarian meta-
stasis was found in 0.5% of cases of renal cell cancer.2 There 
are few reported cases of a primary transitional cell carcinoma 
(TCC) of the renal pelvis metastatic to the ovary.3 The pur-
pose of this report is to present two cases of ovarian meta-
stasis from TCC of urinary tract origin and to provide a brief 
review of the literature.
CASE REPORTS
1. Case 1
A 65-year-old woman with a left ovarian mass was referred 
to the gynecology department. She had received total abdomi-
nal hysterectomy due to a leiomyoma several years ago. She 
was diagnosed with TCC of the renal pelvis 4 months prior 
and underwent right nephroureterectomy with bladder cuff 
resection (Fig. 1A).
Postoperatively, she was seen for regular follow-up; her urol-
ogist obtained a computed tomography (CT) of her abdomen 
for surveillance. The CT revealed a 4.4×2.9 cm solid mass in 
the left adenexa, suggestive of an ovarian tumor. There was no 
evidence of abnormal lymphadenopathy, no obvious meta-
static foci in other organs. Routine blood and biochemical test 
results were all within normal ranges. Before surgery, the ini-
tial investigation of tumor markers revealed a serum CA-125 
of 4.8 U/mL, and other markers were all within normal 
ranges. She underwent bilateral salpingo-oophorectomy. At 
the time of surgery, a 4.5×4.5×4 cm left ovarian mass was 
noted with no evidence of any intraperitoneal or omental 
metastasis. The surface was smooth and glistening without 
perforation (Fig. 1B). The cut surface was yellowish-tan with 
multifocal, slightly whitish areas, and multiple fibrous septae 
were noted. Some small, cystic spaces containing clear, muci-
nous fluid were seen. The right ovary, fallopian tube and the 
cytology of peritoneal fluid was negative for malignant cells. 
The tumor cells were microscopically identical to those of the 
renal pelvis tumor (Fig. 1C, D).
After recovering from surgery, she received six cycles of chemo-
therapy with gemcitabine-carboplatin. The patient is presently 
doing well without any recurrent disease as of November, 2008.
2. Case 2
A 47-year-old woman was referred to our institution because 
of a right ovarian mass that was noticed by her urologist dur-
ing a routine CT of her abdomen. She had a past history of a 
radical cystectomy with neobladder 1 year prior for papillary 
TCC of the bladder, high grade, with lymph node metastasis. 
Postoperatively, she received only one cycle of chemotherapy 
with gemcitabine and cisplatin because of her poor general 
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Fig. 1. (A) Gross appearance of the 
right kidney and ureter showing 
TCC of the renal pelvis. (B) Gross 
appearance of the left ovary show-
ing a solid rubbery mass that near-
ly replaces the ovarian parenchyma. 
(C) Microscopic finding of transi-
tional cell carcinoma of the renal 
pelvis (H&E,　×100). (D) Metastatic
transitional cell carcinoma of the 
ovary (H&E, ×200).
condition. She received regular follow-up and was asymptomatic. 
A CT imaging showed an 8×6.4×8.4 cm newly-developed 
mass in the right adnexa, suggestive of ovarian malignancy. 
Multiple borderline-sized para-aortic and aorto-caval lymph 
nodes were noted. Routine blood and biochemical test results 
were all within normal ranges. Before surgery, CA-19-9 was 
116 U/mL, but other markers were all within normal ranges. 
She underwent a total abdominal hysterectomy with bilateral 
salpingo-oophorectomy and infracolic omentectomy. A 10× 
7×5 cm sized right ovarian mass was noted with no evidence 
of any intraperitoneal or omental metastasis. The ovary was 
cystically enlarged with a gray-white, smooth inner surface. 
Yellow-white solid areas were noted with spotty necrosis. The 
right ovary tumor cell was metastatic TCC. Immunohisto-
chemical stains for cytokeratin 7, 13, 20 were positive. The 
left ovary and fallopian tube were negative for tumor.
She received three cycles of chemotherapy with gemcitabine 
after the surgery, and died 6 months later due to acute renal 
failure.
DISCUSSION
The ovaries are common sites for intra-abdominal meta-
stasis. About 6% of ovarian cancers found at laparotomy are 
secondary tumors from other sites.4 In a register study, ovar-
ian metastasis from a primary renal tumor was found to be 
0.8 %.5 In the literature, only 14 cases have been reported. Of 
these, 13 cases were metastases of renal adenocarcinoma of 
clear cell type, and only one case was from a TCC of the renal 
pelvis.5 The most common renal tumor to metastasize to the 
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Table 1. Primary urinary tract-transitional cell carcinoma (literature review and present cases)
Investigator Age, yr Symptom Primary site Secondary site
Metachronous/
Synchronous
Treatment Disease status
Raabe et al.10 45 Hematuria Left kidney Left ovary M-1 yr Surgery Alive 7 yr
Hsiu et al.3 48 Hematuria, pelvic mass Right kidney Right ovary S Surgery, chemotherapy DOD 6 mo
Ishii et al.11 49 Pelvic mass, hematuria Bladder Right ovary S Surgery, chemotherapy Alive 3 yr
Kardar et al.12 60 Pelvic mass Bladder Left ovary M-4 yr Surgery DOD 3 mo
Case 1 65 Pelvic mass Right kidney Left ovary M-4 mo Surgery, chemotherapy Alive 1 yr
Case 2 47 Pelvic mass Bladder Right ovary M-1 yr Surgery, chemotherapy DOD 6 mo
M: metachronous, S: synchronous, DOD: dead of disease
ovary is a typical clear cell carcinoma. Metastatic TCC involv-
ing the ovary from the urinary bladder or elsewhere within the 
urinary is extremely rare.6 There have been six cases reported 
to date, as summarized in Table 1. In all cases, secondary ovar-
ian tumors are unilateral. The time interval of appearance of 
ovarian metastases varied from synchronous to 4 years. All 
cases received surgery, with the overall survival ranging from 
3 months to 7 years.
Microscopically, metastatic TCC of ovary is very similar to a 
primary ovarian TCC. Primary TCC accounts for 1% to 2% of 
all ovarian tumors.7 TCC of the ovary is a recently recognized 
subtype of ovarian surface epithelial-stromal cancer, and stud-
ies of its morphology are rare. The presence of a component of 
benign or borderline Brenner tumor confirms an ovarian 
primary. TCC of the ovaries has mucin pools, thick papillae with 
smooth luminal borders, in contrast to the pseudo-papillae of 
tumor cell necrosis that is common in metastatic TCC.8
The current cases favor metastatic ovarian tumors for the 
following reasons: Definite histological evidence of a primary 
renal tumor, and deep stromal invasion. The origin of primary 
lesions has prognostic significance because TCC of the ovary 
has a modest response to chemotherapy8 and metastatic TCC 
from the renal pelvis is universally fatal.
In a previous review, a delay in diagnosis of the primary le-
sion from the kidney occurred in 38% of patients with pre-
senting symptoms corresponding to the metastatic site rather 
than the primary lesion.9 Limited evidence suggests that sur-
gical extirpation of both lesions may lead to long-term dis-
ease-free survival.9 Thus, timely diagnosis of the primary le-
sions is critical.
To the best of our knowledge, this is the first report of case 
series of the TCC with primary renal pelvis, bladder tumor 
and ovarian metastasis. This report may help improve the cur-
rent understanding of metastatic ovarian cancer.
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